Maxcyte (MXCT) Leases (2020 - 2026)

Maxcyte (MXCT) has 7 years of Leases data on file, last reported at $10.7 million in Q1 2026.

• Quarterly Leases fell 7.3% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.7 million (down 7.3% YoY) and the FY2025 annual result came in at $10.9 million, up 1.43% from the prior year.
• Leases eased to $10.7 million in Q1 2026 per MXCT's latest filing, from $10.9 million in the prior quarter.
• Across five years, Leases topped out at $11.5 million in Q1 2025 and bottomed at $9.6 million in Q3 2023.
• The 5-year median for Leases is $10.9 million (2024), against an average of $10.6 million.
• The widest annual swing landed in 2022, when Leases jumped 870.86%; it then slipped 10.5% in 2023.
• Tracing MXCT's Leases over 5 years: stood at $9.9 million in 2022, then increased by 14.09% to $11.2 million in 2023, then slipped by 4.23% to $10.8 million in 2024, then climbed by 1.43% to $10.9 million in 2025, then decreased by 2.02% to $10.7 million in 2026.
• Per Business Quant, the three latest MXCT Leases figures stand at $10.7 million (Q1 2026), $10.9 million (Q4 2025), and $11.1 million (Q3 2025).

Peer Comparison